Fortified S-Allyl L-Cysteine: Animal Safety, Effect on Retinal Ischemia, and Role of Wnt in the Underlying Therapeutic Mechanism

Table 2

The effect on electroretinogram a-wave amplitudes (mV) changes after oral gavage for 4 weeks of preischemia daily doses of SAC or Vehicle treatment.

Time/group	Vehicle	SAC 0.18 mg	SAC 0.018 mg	SAC 0.0018 mg
Baseline	0.08 ± 0.02	0.06 ± 0.02	0.09 ± 0.02	0.07 ± 0.02
Week 1	0.01 ± 0.03	0.09 ± 0.02	0.07 ± 0.02	0.05 ± 0.01
Week 2	0.09 ± 0.03	0.08 ± 0.02	0.10 ± 0.02	0.06 ± 0.02
Week 3	0.07 ± 0.02	0.07 ± 0.02	0.06 ± 0.02	0.06 ± 0.02
Week 4	0.09 ± 0.03	0.07 ± 0.02	0.09 ± 0.02	0.06 ± 0.01